The recall affects more than 80,000 packs of Sertraline, which is one of the most commonly prescribed SSRIs for treating depression and anxiety. The incorrect packaging resulted from an error during the secondary packaging process, where blister strips were placed into cartons.

Health authorities have urged patients who have received packs from batch number V2500425 to verify their medication immediately. Dr. Alison Cave emphasized the importance of checking prescriptions, stating, “If you have been prescribed Sertraline 100mg tablets and have received batch number V2500425, please check the carton contains the right medication.”

Patients who mistakenly took Citalopram instead of Sertraline may experience increased serotonergic side effects. These can include nausea, headache, sleep changes, and mild anxiety. Dr. Cave advised affected individuals to seek medical advice promptly.

This incident highlights critical issues surrounding patient safety in mental health treatment. SSRIs like Sertraline and Citalopram play vital roles in managing mental health conditions, and ensuring correct medication is essential for effective treatment.

The total batch size for this recall reached 81,872 packs, reflecting the widespread impact of this error. In 2019 alone, over 16.7 million prescriptions for Sertraline were issued by GPs in England, indicating its popularity among healthcare providers.

The Medicines and Healthcare products Regulatory Agency (MHRA) continues to monitor the situation closely as Amarox Limited works to resolve the issue and prevent future occurrences.

This situation serves as a reminder of the importance of vigilance in pharmaceutical practices and reinforces the need for stringent checks during packaging processes to uphold patient safety standards.

The post Antidepressants recall appeared first on News-UK.